NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

The effects of 0.1 and 1.0 per cent erythrocytes and hemolysis on serum chemistry values.

Author(s): Laessig RH, Hassemer DJ, Paskey TA, Schwartz TH

Publication: Am J Clin Pathol, 1976, Vol. 66, Page 639-44

PubMed ID: 970364 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of contamination of serum with intact or hemolyzed red blood cells on serum chemistry values.

Conclusion of Paper

Contamination of serum with 0.1% or 1% non-hemolyzed erythrocytes had no effect on any of the 40 tests performed in this study. Contamination of serum with 1% hemolyzed erythrocytes turned the serum a cherry red color which would most likely lead to rejection of the specimen for analysis. Indeed this level of contamination led to gross changes in clinical chemistry values. Importantly, contamination of serum with 0.1% hemolyzed erythrocytes caused significant increases in lactate dehydrogenase, aspartate aminotransferase, creatine phosphokinase, alanine aminotransferase, iron, and iron-binding capacity, and potassium. Contamination at this level was not visually apparent and these specimens would most likely not be rejected for analysis in a clinical setting on the basis of hemolysis.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of contamination of serum with intact or hemolyzed red blood cells on serum chemistry values. Whole blood, with or without sodium saponin-induced hemolysis, was added to serum from healthy individuals and 40 clinical chemistry tests were performed.

    Summary of Findings:

    Contamination of serum with 0.1% or 1% non-hemolyzed erythrocytes had no effect on any of the 40 tests performed in this study. Contamination of serum with 1% hemolyzed erythrocytes turned the serum a cherry red color which would most likely lead to rejection of the specimen for analysis. Indeed this level of contamination led to gross changes in clinical chemistry values including increased calcium, phosphorus, total protein, magnesium, albumin, and direct cholesterol levels in addition to increases seen with 0.1% hemolyzed erythrocytes. Importantly, contamination of serum with 0.1% hemolyzed erythrocytes caused significant increases in lactate dehydrogenase, aspartate aminotransferase, creatine phosphokinase, alanine aminotransferase, iron, and iron-binding capacity, and potassium. Contamination at this level was not visually apparent and these specimens would most likely not be rejected for analysis in a clinical setting on the basis of hemolysis.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Electrolyte/Metal Clinical chemistry/auto analyzer
    Electrolyte/Metal Flame emission photometry
    Carbohydrate Clinical chemistry/auto analyzer
    Steroid Clinical chemistry/auto analyzer
    Lipid Clinical chemistry/auto analyzer
    Protein Clinical chemistry/auto analyzer
    Protein Spectrophotometry
    Peptide Clinical chemistry/auto analyzer
    Small molecule Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Biospecimen components Serum
    0.1% erythrocytes in serum
    0.1% hemolyzed erythrocytes in serum
    1% erythrocytes in serum
    1% hemolyzed erythrocytes in serum
    Serum with sodium saponin
    Biospecimen Aliquots and Components Hemolysis Hemolysate added
    No hemolysate added
    Chemically-induced

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...